At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase III Randomized Trial of Pulse Actinomycin-D Versus Multi-day Methotrexate for the Treatment of Low-Risk Gestational Trophoblastic Neoplasia
In Brief
A Phase 3 clinical trial evaluating Dactinomycin, Leucovorin Calcium, and 2 other interventions for Choriocarcinoma and 4 related conditions. Completed, enrolled 57 participants across 289 sites in 5 countries.
Detailed Summary
This randomized phase III trial studies how well methotrexate works compared to dactinomycin in treating patients with low-risk gestational trophoblastic neoplasia. Drugs used in chemotherapy, such as methotrexate and dactinomycin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. It is not yet known whether methotrexate is more effective than dactinomycin in treating gestational trophoblastic disease.
Study Details
Timeline
Interventions
Given IV
Given PO
Given IV and IM
Ancillary studies